Search

Phosphogypsum (PG), which is a solid waste in phosphate fertilizer industry, is harmful to the environment. The pyrogenetic decomposition is mainly used in the utilization of PG, and PG decomposition residue is produced in the decomposition process. In this paper, the migration and conversion rules of elements (Al, Si, P, K, Ca, and Fe) in the purification procedure of CaO in PG decomposition residue was investigated. The acid–base method was used to purify CaO. Content and chemical forms of elements in the purification procedure were analyzed by many characterization methods such as SEM and EDS. And moreover, changes on chemical forms of elements were supported theoretically by some ternary phase diagrams, which were made by the FactSage thermodynamics software. The result showed that, the soluble silicon dioxide and the acid‐insoluble material in PG decomposition residue were effectively removed by using the acid–base method. Meanwhile, impurities separated from CaO and the CaO sample were produced in the experiment, the former can be used to produce the building materials, refractories, insulating materials in various industrial fields, and CaO sample could be used as the filler, building materials, decolorant, etc. © 2017 American Institute of Chemical Engineers Environ Prog, 37: 1020–1030, 2018 [ABSTRACT FROM AUTHOR]

Background: Thrombopoietin receptor agonists (TPO-RAs) are currently approved for the treatment of thrombocytopenia in different conditions. The relationship between TPO-RAs and thromboembolic events (TEEs) remains controversial., Research Design and Methods: We extracted TPO-RAs adverse reaction reports after their marketing until now, using the FDA adverse event reporting system (FAERS). Positive signals were detected by reporting odds ratios (RORs). And the Weibull shape parameter test was utilized to analyze the time-to-onset profiles., Result: Thromboembolic events accounted for 8.97% among TPO-RAs reports. Increased reporting of TEEs was related to TPO-RAs treatment compared with the entire FAERS database [ROR = 2.65 (2.56, 2.73)]. In addition, venous thrombotic events [ROR = 4.13 (3.92, 4.35)] were reported more frequently than arterial events ROR = 1.81 (1.7, 1.93)]. Age over 60 years [odds ratio (OR) = 1.10 (1.01, 1.20), p  = 0.029] and weight over 80 kg [OR = 1.36 (1.17, 1.58), p  < 0.001] of patients might have higher risk of TEEs during TPO-RAs therapy., Conclusion: Evidence from the real world suggested that TPO-RAs were associated with higher incidence of TEEs, particularly venous thrombosis. The risk of TPO-RAs-associated TEEs mostly happened in the early stages of treatment and decreased over time.